Celdaz 200mg Injection

Celdaz 200mg Injection belongs to the category of anticancer medicines. These medicines are primarily used to treat patients diagnosed with metastatic malignant melanoma (skin cancer) and Hodgkin's disease (cancer that forms in the lymph system). The growth of cancer cells is uncontrollable and abnormal in the human body. It is difficult to diagnose cancer in the early stages. When diagnosed in advanced stages, only the symptoms of the disease can be reduced. Celdaz Injection is usually given as a monotherapy drug for treating Hodgkin's disease patients who cannot tolerate other chemotherapy treatments.